Our retrospective study showed ERBB2 CNG in breast cancer cases has a high PPV for HER2-positivity by IHC/FISH by ASCO/CAP 2018 guidelines (PPV for tissue NGS 97%, ctDNA 93%). This evidence concerns the gene ERBB2 and breast carcinoma.